• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.87% Nasdaq Up0.34%

    Foundation Medicine, Inc. (FMI)

    24.37 Up 0.30(1.25%) 4:00PM EST
    |After Hours : 24.37 0.00 (0.00%) 4:35PM EST
    Add to Portfolio
    CompetitorsGet Competitors for:
    Direct Competitor Comparison 
    Market Cap:689.91MN/A1.03B2.64BN/A
    Qtrly Rev Growth (yoy):1.00N/A0.05-0.170.00
    Revenue (ttm): 52.06MN/A275.40M744.59MN/A
    Gross Margin (ttm):0.55N/A0.780.840.00
    EBITDA (ttm):-44.86MN/A-19.38M247.48MN/A
    Operating Margin (ttm): -1.01N/A-0.090.310.00
    Net Income (ttm):-52.02MN/A-27.69M136.74MN/A
    EPS (ttm):-1.87N/A-0.891.78N/A
    P/E (ttm):N/AN/AN/A20.35N/A
    PEG (5 yr expected):N/AN/A2.011.29N/A
    P/S (ttm):13.09N/A3.613.57N/A
    Pvt1 = Clarient, Inc. (privately held)
    GHDX = Genomic Health Inc.
    MYGN = Myriad Genetics Inc.
    Industry = Medical Laboratories & Research

    News on Direct Competitors 

    Currency in USD.